Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Lancet (London, England)|September 20, 2025
Oncolytic viruses as anticancer agents: clinical progress and remaining challengesElizabeth Appleton, E Antonio Chiocca, Guy Ungerechts, et al.
Viruses|December 4, 2015
Evidence for Oncolytic Virotherapy: Where Have We Got to and Where Are We Going?Samantha Turnbull, Emma J West, Karen J Scott, et al.
Frontiers in Immunology|November 4, 2021
Kickstarting Immunity in Cold Tumours: Localised Tumour Therapy Combinations With Immune Checkpoint BlockadeElizabeth Appleton, Jehanne Hassan, Charleen Chan Wah Hak, et al.
Science Advances|June 5, 2026
Engagement of the TCR against an oncolytic virus generates a population of effector CAR T cells with potent antitumor activityOlivia Liseth, Elizabeth Appleton, Benjamin Kendall, et al.
Research Square|November 28, 2024
Cancer Immunotherapy Using AIRE Conditioning of the Tumor EpitopeomeRichard Vile, Jose Pulido, Alex Chen, et al.
Gut|December 1, 2016
Oncolytic reovirus as a combined antiviral and anti-tumour agent for the treatment of liver cancerAdel Samson, Matthew J Bentham, Karen Scott, et al.
Journal for Immunotherapy of Cancer|September 26, 2025
Addition of oncolytic virotherapy to clinical isolated limb perfusion for melanoma and sarcoma activates antitumor immunityAndrew J Hayes, Emma J Davies, Michelle Wilkinson, et al.
Nature Communications|July 8, 2025
The PARP inhibitor talazoparib synergizes with reovirus to induce cancer killing and tumour control in vivo in mouse modelsJoan Kyula-Currie, Victoria Roulstone, James Wright, et al.
Nature Communications|May 24, 2025
Palbociclib and dsRNA sensor co-operate to enhance anti-cancer effects through ER stress and modulation of immune evasionVictoria Roulstone, Joan Kyula-Currie, James Wright, et al.
Pageof 2